Tiantian Hu's research while affiliated with Fudan University and other places

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (1)


Overview of tumor immunotherapy based on approved drugs
  • Literature Review

January 2024

·

4 Reads

·

1 Citation

Life Sciences

Ziqin Chen

·

Tiantian Hu

·

·

[...]

·

Share

Citations (1)


... There are several types of immunotherapy to boost the immune response via employing a different strategy (72). Checkpoint inhibitors were discovered, which block proteins that prevent immune cells from attacking cancer cells (73). By inhibiting these "checkpoints", checkpoint inhibitors enable the immune cells to recognize and destroy cancer cells, including inhibitors targeting PD-1, PD-L1, and CTLA-4 (74). ...

Reference:

PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Overview of tumor immunotherapy based on approved drugs
  • Citing Article
  • January 2024

Life Sciences